
Amyntas Pharma Private Limited
About Amyntas Pharma Private Limited
Data last updated:
Amyntas Pharma Private Limited is a private limited company based in Vaijapur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33302MH2017PTC291193.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Apoorva Amar Shedge and Harshal Chandrakant Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No.873 Kazi Galli, Vaijapur, Maharashtra, India – 423701.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Amyntas Pharma
Contact details
Amyntas Pharma Private Limited's registered office is in Vaijapur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH. No.873 Kazi Galli, Vaijapur, Maharashtra, India – 423701
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Amyntas Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Amyntas Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Amyntas Pharma Private Limited, buy the company report.
Board of directors of Amyntas Pharma Private Limited
Amyntas Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Apoorva Amar Shedge | Director | 19 Sep 2024 | 2 Years 2 Months | Current |
| Harshal Chandrakant Patil | Director | 19 Sep 2024 | 2 Years 2 Months | Current |
| Sajjadali Riyasatali Syed Also directs: Genmeds Healthcare LLP, Twinpeaks Impex LLP, Biovion Pharma Private Limited and 1 more | Director | 19 Sep 2024 | 2 Years 2 Months | Current |
Auditor
Amyntas Pharma Private Limited is audited by HAKEEM AND ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HAKEEM AND ASSOCIATES | FY 2020 | 137304W |
Shareholding
The shareholding of Amyntas Pharma Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Amyntas Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amyntas Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amyntas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Amyntas Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Amyntas Pharma Private Limited has 7 board changes on record since 2022: 3 appointments and 4 cessations. The latest: Apoorva Amar Shedge was appointed as Director on 19 Sep 2024.
Frequently asked questions
Amyntas Pharma is an active private limited company based in Vaijapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 2017 (9+ years old) and is registered under CIN U33302MH2017PTC291193.
Amyntas Pharma has 3 current directors:
- Apoorva Amar Shedge - Director
- Harshal Chandrakant Patil - Director
- Sajjadali Riyasatali Syed - Director
The latest financial statements of Amyntas Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Amyntas Pharma is U33302MH2017PTC291193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amyntas Pharma was incorporated on 14 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Apoorva Amar Shedge was appointed as Director on 19 Sep 2024. Harshal Chandrakant Patil was appointed as Director on 19 Sep 2024. Sajjadali Riyasatali Syed was appointed as Director on 19 Sep 2024. Amyntas Pharma has 7 board changes on record in total.
Yes, Amyntas Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Amyntas Pharma is at H. No.873 Kazi Galli, Vaijapur, Maharashtra, India – 423701.
Amyntas Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Amyntas Pharma is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.

